[Federal Register Volume 87, Number 24 (Friday, February 4, 2022)]
[Notices]
[Pages 6554-6555]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-02404]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-22-20MR; Docket No. CDC-2022-0018]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a proposed 
information collection project titled Leptospirosis and Melioidosis 
Active Hospital-based Surveillance in Puerto Rico. The project aims to 
identify leptospirosis and melioidosis cases in Puerto Rico by 
establishing active surveillance for both diseases at four hospital 
sites for disease identification and treatment and to improve 
understanding of leptospirosis and melioidosis epidemiology and ecology 
in Puerto Rico for public health control and prevention planning.

DATES: CDC must receive written comments on or before April 5, 2022.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0018 by either of the following methods:
    <bullet> Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
    <bullet> Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS H21-8, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (regulations.gov) or by U.S. mail to the address listed above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS H21-8, Atlanta, Georgia 30329; phone: 404-639-7570; Email: 
<a href="/cdn-cgi/l/email-protection#a6c9cbc4e6c5c2c588c1c9d0"><span class="__cf_email__" data-cfemail="2f40424d6f4c4b4c01484059">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected;
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses; and
    5. Assess information collection costs.

Proposed Project

    Leptospirosis and Melioidosis Active Hospital-based Surveillance in 
Puerto Rico--Existing Collection in Use Without an OMB Control Number--
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), 
Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    This project aims to identify leptospirosis and melioidosis cases 
in Puerto Rico by establishing active surveillance for both diseases at 
four hospital sites for timely disease identification and treatment and 
to improve understanding of leptospirosis and melioidosis epidemiology 
and ecology in Puerto Rico for public health control and prevention 
planning. Both diseases can cause outbreaks after hurricanes and 
flooding, especially in tropical areas, and this project is being 
conducted in response to an increase in leptospirosis cases after 
Hurricanes Irma and Maria in 2017.
    Participants will be recruited from the population presenting to 
the emergency department of the four hospital sites with febrile 
illness, and will be interviewed to gather information on symptoms, 
possible exposures, and medical history, in addition to having 
diagnostic samples collected to test for leptospirosis plus or minus 
melioidosis (depending on presenting symptoms). Participants will also 
be interviewed approximately two weeks after enrollment to determine 
illness progression and outcome. Patients testing positive for 
leptospirosis, if willing, may have animal samples taken from their 
home or work environments to help determine the animal reservoirs 
related to human leptospirosis illness in Puerto Rico.
    CDC requests OMB approval for an estimated 1,675 annual burden 
hours. There is no cost to respondents other than their time to 
participate.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                                    Number of        Number of      burden per     Total burden
     Type of respondents           Form name       respondents     responses per   response (in     (in hours)
                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
Patient......................  PIFA (screening)  Up to 7,000....               1            5/60             583

[[Page 6555]]

 
Patient......................  PIFA (full form:  Up to 3,000....               1           10/60             500
                                sections 1-4,
                                11).
Patient......................  Consent Form....  Up to 3,000....               1            6/60             300
Patient......................  PIFF............  Up to 1,000....               1           10/60             167
Patient......................  Animal Household  Up to 250......               1           30/60             125
                                Survey.
                                                                 -----------------------------------------------
    Total....................  ................  ...............  ..............  ..............           1,675
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-02404 Filed 2-3-22; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>